Synucure Therapeutics is a Canadian biotechnology business that operates research on degenerative brain illnesses.
Synucure Therapeutics has raised $2.8M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Synucure Therapeutics's investors include Investissement Quebec.
Synucure Therapeutics is headquartered in Montreal, Canada.
Synucure Therapeutics is a Canadian biotechnology business that operates research on degenerative brain illnesses.
Synucure Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synucure Therapeutics — Funding & Investors." VCBacked, April 7, 2025, https://www.vcbacked.co/company/synucure-therapeutics. Accessed September 15, 2026.
VCBacked. (2025). Synucure Therapeutics — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/synucure-therapeutics
{{cite web |title=Synucure Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/synucure-therapeutics |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated